Literature DB >> 2305025

Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.

A Walker1, J Bancroft.   

Abstract

Patterns of menstrual cycle-related change were compared in three groups of women differing in their use of oral contraceptives and being matched for age, occupation, and parity. These groups were: a "monophasic group" (n = 35) established on low dose "combined" pills with stable levels of estrogen and progestagen. a "triphasic group" (n = 30) on low dose pills with escalating progestagen dosage, and a "non-pill control group" (n = 57) using nonsteroidal contraceptives. Each woman kept visual analogue ratings of mood, irritability, energy, tension, breast tenderness, bloating, and sexual interest for two or three cycles. Cyclicity was evident in all variables assessed, but the only variable to show a clear difference between groups was breast tenderness; the "monophasic group" showed less premenstrual breast tenderness than the other two groups. The monophasic group also showed a tendency to menstrual rather than premenstrual symptoms. In view of the similarity of timing of most cyclical symptoms in the three groups, it is difficult to attribute such cyclical phenomena to the effects of either ovulation or variation in corpus luteum function. For most subjects, the cyclical changes were relatively mild, and these findings need to be replicated in women suffering from severe premenstrual syndrome. However, alternative explanations need to account for changes in women both taking and not taking oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305025     DOI: 10.1097/00006842-199001000-00007

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  14 in total

Review 1.  Neuroendocrine effects on mood.

Authors:  Margaret G Spinelli
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

2.  Sex differences and hormonal influences on response to mechanical pressure pain in humans.

Authors:  William J Kowalczyk; Maria A Sullivan; Suzette M Evans; Adam M Bisaga; Suzanne K Vosburg; Sandra D Comer
Journal:  J Pain       Date:  2009-10-22       Impact factor: 5.820

3.  Oral contraceptives and sexuality in university women.

Authors:  N L McCoy; J R Matyas
Journal:  Arch Sex Behav       Date:  1996-02

Review 4.  Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?

Authors:  Uriel Halbreich; P M Shaughn O'Brien; Elias Eriksson; Torbjörn Bäckström; Kimberly A Yonkers; Ellen W Freeman
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome.

Authors:  Kimberly A Yonkers; Brianna Cameron; Ralitza Gueorguieva; Margaret Altemus; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2016-11-17       Impact factor: 2.681

6.  Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women.

Authors:  Anouk E de Wit; Sanne H Booij; Erik J Giltay; Hadine Joffe; Robert A Schoevers; Albertine J Oldehinkel
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

Review 7.  Helping women with premenstrual syndrome.

Authors:  P M O'Brien
Journal:  BMJ       Date:  1993-12-04

8.  Oral contraceptive use and psychiatric disorders in a nationally representative sample of women.

Authors:  Keely Cheslack-Postava; Katherine M Keyes; Sarah R Lowe; Karestan C Koenen
Journal:  Arch Womens Ment Health       Date:  2014-08-13       Impact factor: 3.633

Review 9.  The role of hormones and hormonal treatments in premenstrual syndrome.

Authors:  Torbjörn Bäckström; Lotta Andreen; Vita Birzniece; Inger Björn; Inga-Maj Johansson; Maud Nordenstam-Haghjo; Sigrid Nyberg; Inger Sundström-Poromaa; Göran Wahlström; Mingde Wang; Di Zhu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.